New shot targets kidney disease: early trial begins
NCT ID NCT05668403
First seen May 05, 2026 · Last updated May 05, 2026
Summary
This early-phase study tests a new injectable antibody (anti-CD20) for primary membranous nephropathy, a kidney disease where the immune system attacks the kidneys. The trial will enroll 52 adults to check safety, how the drug moves through the body, and whether it shows signs of working. The goal is to control the disease by targeting immune cells, not to cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY MEMBRANOUS NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hebei General Hospital
RECRUITINGShijiazhuang, Hebei, 050057, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Longhua Hospital Shanghai University of Traditional Chinese Medicine
RECRUITINGShanghai, 200032, China
-
Longhua Hospital Shanghai University of Traditional Chinese Medicine
RECRUITINGShanghai, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peking university first hospital
RECRUITINGBeijing, 100010, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, He'nan, 410100, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital,College of Medicine,Zhejiang University
RECRUITINGHangzhou, Zhejiang, 310003, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.